ARKIVOC is an esteemed open-access journal dedicated to the field of Organic Chemistry, published by ARKAT USA INC. Since its inception in 2000, ARKIVOC has aimed to disseminate high-quality research and advancements in organic chemistry, fostering an international exchange of knowledge within this ever-evolving discipline. With its ISSN 1551-7004 and E-ISSN 1551-7012, the journal is committed to providing accessible content free of charge to researchers, students, and professionals around the globe. Although currently categorized in the fourth quartile of Organic Chemistry with a Scopus rank of #188 out of 211, ARKIVOC continues to encourage the publication of innovative works and critical reviews that highlight emerging trends and methodologies in organic synthesis, reaction mechanisms, and material sciences. Its open-access model since 2000 ensures that valuable contributions to scientific knowledge are widely available, promoting collaboration and discovery. The journal is based in the United States, with its editorial office located at the University of Florida, under the guidance of prominent chemists. ARKIVOC provides an essential platform for those deeply engaged in organic chemistry research, supporting the advancement of science for future generations.

Mini-Reviews in Organic Chemistry, published by Bentham Science Publishers, is an esteemed journal in the field of organic chemistry, dedicated to presenting concise, thoughtful reviews that encapsulate the rapid advancements in this dynamic area of study. Since its inception in 2005, the journal has become a valuable resource for researchers, professionals, and students interested in the latest developments and trends, featuring an HIndex indicative of its scholarly impact. With its 2023 Scopus ranking placing it in the 52nd percentile and categorized as Q3 in Organic Chemistry, it offers insights that bridge the gap between fundamental research and practical applications. While not an open-access journal, it provides significant access options for institutional journals and library systems. Situated in the United Arab Emirates, Mini-Reviews in Organic Chemistry continues to serve as a beacon for innovation and knowledge dissemination in organic chemistry, ensuring that its audience remains at the forefront of scientific discovery.

BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.

RUSSIAN CHEMICAL BULLETIN, published by SPRINGER, serves as a pivotal resource in the field of general chemistry, covering a wide array of topics that impact both theoretical and applied chemistry. With an ISSN of 1066-5285 and a presence since 1993, this journal provides a platform for disseminating significant research findings, practical applications, and novel methodologies within the broader chemistry community. While it currently holds a Q3 ranking in the Chemistry (miscellaneous) category and occupies the 230th position out of 408 in the Scopus rankings, its reputation continues to grow, fostering collaboration and innovation among researchers and professionals alike. Although the journal does not offer an open-access model, it is committed to making findings accessible within the academic community, ensuring that valuable insights can inform future research. With an anticipated convergence of studies extending to 2024, the RUSSIAN CHEMICAL BULLETIN remains an essential reference for those dedicated to advancing chemical science.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.

Journal of Natural Medicines, published by SPRINGER JAPAN KK, is a leading academic journal that plays a pivotal role in the advancement of research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, and Pharmaceutical Science. Established in 1994 and set to continue until 2024, this journal serves as a vital conduit for the dissemination of groundbreaking research and innovative ideas that bridge traditional medicinal knowledge and modern scientific inquiry. With its impressive ranking in Scopus—ranking #12 out of 105 in Complementary and Alternative Medicine and holding a Q1 category quartile for 2023—it stands as a reputable source for high-quality, peer-reviewed articles. The journal's commitment to excellence is further underscored by its inclusion in the Springer network, providing researchers, professionals, and students with valuable insights and the latest developments in natural medicines. Although this journal operates under a subscription model, its profound impact on these interdisciplinary fields makes it an essential resource for anyone engaged in the study or practice of natural medicinal therapies.

LETTERS IN ORGANIC CHEMISTRY is a distinguished journal published by Bentham Science Publishers Ltd, focusing on the rapidly evolving field of organic chemistry. Established in 2005, the journal commits itself to disseminating vital research findings, reviews, and innovative methodologies that contribute to the understanding and advancement of organic chemistry and biochemistry. With an ISSN of 1570-1786 and an E-ISSN of 1875-6255, this journal enhances accessibility and visibility for authors and readers alike, albeit not adopting an open-access model. Positioned within Q4 quartile rankings for both Biochemistry and Organic Chemistry, it serves a niche audience keen on exploring emerging trends and breakthroughs in these disciplines. Its Scopus rankings further reflect its role in the global academic landscape, albeit at the beginning stages of its impact journey. Based in the United Arab Emirates, LETTERS IN ORGANIC CHEMISTRY is dedicated to fostering dialogue among researchers and practitioners, paving the way for future innovations in organic and biochemical sciences.

The Australian Journal of Chemistry, with an ISSN of 0004-9425 and an E-ISSN of 1445-0038, is a distinguished publication from CSIRO PUBLISHING, dedicated to advancing the field of chemistry since its inception in 1948. Based in Australia, this journal serves as a platform for original research articles, reviews, and innovative studies that encompass a wide spectrum of chemical disciplines, aiming to foster communication and collaboration among researchers globally. Despite its Q3 ranking in the Chemistry (Miscellaneous) category and standing at rank #236 in Scopus’ general chemistry classification, it remains an essential resource for professionals and students seeking to stay informed about emerging trends and discoveries in chemistry. The journal does not offer open access, emphasizing the premium quality of peer-reviewed content that adheres to rigorous academic standards. By bridging theory and practice, the Australian Journal of Chemistry continues to play a crucial role in shaping the future of chemical sciences.

Pharmaceutical Chemistry Journal is a pivotal publication in the field of pharmaceutical sciences, renowned for its in-depth articles and research findings. Published by Springer in the United States, this journal provides a crucial platform for researchers, students, and professionals dedicated to advancing drug discovery and pharmacology. With an ISSN of 0091-150X and an E-ISSN of 1573-9031, this journal has consistently aimed to promote scholarly communication and innovation within its scope since its inception in 1967. Despite its current Category Quartiles ranking of Q4 in both Drug Discovery and Pharmacology, the journal remains a valuable resource for disseminating new ideas and findings that contribute to the scientific community. Researchers benefit from the journal's commitment to high-quality peer-reviewed content, even in an environment where open access options are currently not available. As the field evolves, the Pharmaceutical Chemistry Journal continues to play an important role in shaping future advancements in drug development and safety.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.